We use cookies on this site to provide you with an informative and engaging experience and also to help us to continually improve our site for you. Without allowing cookies certain features of the site will not be available. To learn more about how we use cookies, please view our cookie policy. By clicking on ‘APPROVE’, you consent to our use of cookies on this device in accordance with our policy.

Patent Protection for Second Medical Uses Compare Jurisdictions

Select at least 2 jurisdictions and at least 1 topic

1. Select Jurisdiction(s)
  • Australia

  • Brazil

  • Canada

  • China

2. Select Topic(s)
  • Availability of protection
    • Legal framework
      • National statutory laws
        • Pharmaceuticals
        • Biologics
      • International treaties
        • TRIPS
        • FTAs
      • Availability through case law
      • Patent term extension/SPCs
    • Policy considerations
      • Health and social issues
      • Legal issues
  • Validity
    • Allowable claim wording
      • Product claims
      • Method claims
      • Use claims
      • System claims
      • Dosage regimes
      • Patient groups
    • Novelty
      • General definition of novelty and prior art
      • Definition of skilled person
      • Scope of disclosure
        • General rules
        • First medical use
        • New subject matter
        • New data
      • Requirements for second medical use
        • Distinction from first medical use
        • Sub-species of second medical use
        • Dosage regimes
        • Special patient groups
        • Special patient groups
        • Special technical effect or mechanism leading to a truly novel clinical/medical situation
      • Timing issues
        • Relevant time of development of second use
        • Role of new data
        • Use of old data
    • Inventive step/non-obviousness
      • Definition of inventive step/non-obviousness
      • Same scope of disclosure as for novelty
      • Assessment of inventive step/non-obviousness
    • Amendment of claims after grant
      • Admissibility of post-grant amendments in general
      • Procedural issues
        • Independent limitation proceedings
        • Opposition proceedings
        • Nullity actions
      • Added matter
      • Sufficiency
      • Multiple indications
    • Change of patent category
      • General admissibility
      • Use claim as a category
      • From product to method claim
      • From method to product claim
      • System claims
      • Use claims
  • Infringement and litigation
    • Legal framework
      • National statutory laws
      • Case law
    • Claim construction
      • General rules
      • Specific issues for use claims
    • Scope of protection
      • Scope of the use
        • General definition of the term “use”
        • Manufacture of the pharmaceutical
        • Sale of the product
        • Offer for sale
        • Application to the patient
        • Combination products
      • Absolute product protection
        • Limitation through the term “use”
        • Off-label use
      • Dosage regimes
      • Patient groups
      • Extension under the doctrine of equivalents
    • Infringing acts
      • Infringing person or entity
      • Direct infringement
        • Manufacture of the pharmaceutical
        • Offer for sale
        • Sale
        • Export
        • Import
        • Combination products
      • Indirect infringement
        • Objective acts
        • Subjective conditions
        • Export
        • Import
        • Combination products
      • Off-label use
        • General admissibility of off-label use
        • Liable persons
        • Objective requirements for infringement
        • Subjective requirements for infringement
      • Dosage regimes
      • Patient groups
    • V. Remedies
      • Injunctions
      • Damages
      • Information
        • Names of manufacturer, distributors etc.
        • Names of customers
        • Information about infringing sales
        • Account of profits
      • Recall of products and destruction
      • Recovery of legal costs
    • Exceptions from patent protection
      • Exhaustion of rights
      • Patient welfare
      • Others specific to second medical use claims
    • Procedural issues
      • Preliminary injunction cases
        • Availability for second medical use claims
        • Specific requirements
      • Cases on the merits
      • Enforcement of judgments
    • Validity
      • Relevance for infringement cases
      • Specifics for second medical use claims
    • Tactical considerations
      • Plaintiff
      • Defendant